|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000161249 |
Summary for DMKN |
Gene summary |
| Gene information | Ensembl ID | ENSG00000161249 | Gene symbol | DMKN |
| Gene name | dermokine | |
| HGNC | 25063 | |
| Entrez ID | 93099 | |
| Gene type | protein_coding | |
| Synonyms | DMKN|ZD52F10 | |
| UniProtAcc | Q6E0U4 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for DMKN |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| DMKN | 5.43e+02 | -1.41e+00 | 2.95e-01 | -4.78e+00 | 1.75e-06 | 4.26e-05 | LIHC |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| DMKN | 4.65e+03 | 1.19e+00 | 2.77e-01 | 4.31e+00 | 1.62e-05 | 2.94e-05 | LUSC |
| DMKN | 6.14e+03 | 2.03e+00 | 6.35e-01 | 3.20e+00 | 1.37e-03 | 4.33e-03 | BLCA |
| DMKN | 1.81e+03 | -1.59e+00 | 4.22e-01 | -3.78e+00 | 1.59e-04 | 5.52e-04 | STAD |
| DMKN | 3.38e+03 | 4.73e+00 | 5.56e-01 | 8.51e+00 | 1.67e-17 | 1.12e-15 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| DMKN | 1.01e+03 | -1.22e+00 | 3.87e-01 | -3.14e+00 | 1.67e-03 | 3.44e-03 | KIRC |
| DMKN | 7.91e+02 | 2.88e+00 | 5.62e-01 | 5.12e+00 | 3.09e-07 | 1.76e-06 | LIHC |
Top |
Sex-biased somatic mutation for DMKN |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for DMKN |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg15078284 | chr19:35514092 | CGI:chr19:35533280-35533901 | promoter | 3.46e-01 | 2.33e-01 | 2.14e+00 | 3.21e-02 | 4.22e-02 | 1.14e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg17662083 | chr19:35513730 | CGI:chr19:35533280-35533901 | promoter | 5.86e-01 | 6.90e-01 | -3.35e+00 | 7.97e-04 | 1.27e-03 | -1.04e-01 |
| LUAD | cg17662083 | chr19:35513730 | CGI:chr19:35533280-35533901 | promoter | 4.85e-01 | 6.08e-01 | -4.53e+00 | 5.96e-06 | 2.77e-05 | -1.23e-01 |
| LUAD | cg10133777 | chr19:35515004 | CGI:chr19:35533280-35533901 | promoter | 7.93e-01 | 9.29e-01 | -3.81e+00 | 1.38e-04 | 3.69e-04 | -1.37e-01 |
| HNSC | cg17662083 | chr19:35513730 | CGI:chr19:35533280-35533901 | promoter | 4.29e-01 | 5.69e-01 | -4.76e+00 | 1.97e-06 | 1.01e-05 | -1.40e-01 |
| HNSC | cg10133777 | chr19:35515004 | CGI:chr19:35533280-35533901 | promoter | 7.87e-01 | 9.20e-01 | -3.85e+00 | 1.21e-04 | 3.03e-04 | -1.33e-01 |
| LUSC | cg17662083 | chr19:35513730 | CGI:chr19:35533280-35533901 | promoter | 4.40e-01 | 6.12e-01 | -3.94e+00 | 8.07e-05 | 6.42e-04 | -1.72e-01 |
| LUSC | cg16677448 | chr19:35513797 | CGI:chr19:35533280-35533901 | promoter | 2.81e-01 | 3.82e-01 | -3.34e+00 | 8.25e-04 | 2.29e-03 | -1.01e-01 |
| LUSC | cg17112426 | chr19:35513814 | CGI:chr19:35533280-35533901 | promoter | 3.50e-01 | 4.97e-01 | -3.49e+00 | 4.91e-04 | 1.64e-03 | -1.47e-01 |
| LUSC | cg10133777 | chr19:35515004 | CGI:chr19:35533280-35533901 | promoter | 8.08e-01 | 9.24e-01 | -2.19e+00 | 2.82e-02 | 3.14e-02 | -1.16e-01 |
| BLCA | cg10133777 | chr19:35515004 | CGI:chr19:35533280-35533901 | promoter | 7.73e-01 | 9.32e-01 | -3.42e+00 | 6.31e-04 | 1.59e-03 | -1.58e-01 |
| LIHC | cg15078284 | chr19:35514092 | CGI:chr19:35533280-35533901 | promoter | 2.79e-01 | 4.25e-01 | -4.84e+00 | 1.27e-06 | 4.56e-06 | -1.47e-01 |
| CHOL | cg17662083 | chr19:35513730 | CGI:chr19:35533280-35533901 | promoter | 5.40e-01 | 8.01e-01 | -2.65e+00 | 7.96e-03 | 1.92e-02 | -2.61e-01 |
| CHOL | cg16677448 | chr19:35513797 | CGI:chr19:35533280-35533901 | promoter | 4.46e-01 | 7.35e-01 | -2.95e+00 | 3.19e-03 | 1.32e-02 | -2.89e-01 |
| CHOL | cg17112426 | chr19:35513814 | CGI:chr19:35533280-35533901 | promoter | 5.15e-01 | 7.46e-01 | -2.58e+00 | 9.87e-03 | 2.15e-02 | -2.32e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg16677448 | chr19:35513797 | CGI:chr19:35533280-35533901 | promoter | 2.46e-01 | 3.78e-01 | -3.43e+00 | 5.94e-04 | 3.87e-03 | -1.32e-01 |
Top |
Exon skipping events with PSI in TCGA for DMKN |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| LUAD | exon_skip_317360 | 2.57e-01 | 3.60e-01 | -3.59e+00 | 3.24e-04 | 1.27e-03 | -1.03e-01 |
| LUAD | exon_skip_317443 | 6.51e-01 | 7.67e-01 | -3.95e+00 | 7.84e-05 | 4.01e-04 | -1.16e-01 |
| BLCA | exon_skip_317360 | 2.36e-01 | 3.56e-01 | -3.57e+00 | 3.63e-04 | 3.36e-03 | -1.20e-01 |
| ESCA | exon_skip_317378 | 2.05e-01 | 3.41e-01 | -2.98e+00 | 2.87e-03 | 1.48e-02 | -1.36e-01 |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| READ | exon_skip_317443 | 5.38e-01 | 6.88e-01 | -2.14e+00 | 3.26e-02 | 4.06e-02 | -1.50e-01 |
Top |
RNA A-to-I editing events in TCGA for DMKN |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| BRCA | DMKN-067 | chr19_35498238_- | 1.94e-01 | 2.62e-01 | -2.34e+00 | 1.95e-02 | 2.40e-02 | -6.83e-02 |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for DMKN |
TFs related to DMKN.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
DMKN related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for DMKN |
RBPs related to ES in DMKN.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| UVM | PCBP1 | exon_skip_317384 | 9.20e+00 | 1.35e-02 | 9.48e+00 | 9.84e-01 | Female-biased |
| LUSC | BRUNOL6 | exon_skip_317360 | 9.14e+00 | 9.89e-01 | 8.74e+00 | 7.66e-03 | Male-biased |
| BRCA | BRUNOL6 | exon_skip_317360 | 8.78e+00 | 1.24e-02 | 9.37e+00 | 9.84e-01 | Female-biased |
| THCA | BRUNOL6 | exon_skip_317360 | 8.43e+00 | 9.90e-03 | 8.72e+00 | 9.85e-01 | Female-biased |
| MESO | ZFP36 | exon_skip_317435 | 9.20e+00 | 9.90e-01 | 8.80e+00 | 6.61e-03 | Male-biased |
DMKN related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs185434905 | chr19:40086134:T:G | - | 0.125150714672303 | 0.0482575151705219 | HNSC | Female-baised eQTL |
| rs2233152 | chr19:40775111:G:A | - | 0.0424494707469064 | 0.000237314947834792 | THCA | Female-baised eQTL |
| rs17713068 | chr19:40764150:T:G | - | 0.0404685016647095 | 0.000492605151575229 | THCA | Female-baised eQTL |
| rs2287692 | chr19:40783851:G:A | - | 0.0381763294237449 | 0.00117083891511474 | THCA | Female-baised eQTL |
| rs35730269 | chr19:29509770:G:A | - | 0.217869654750819 | 0.000181591138506573 | LUSC | Female-baised eQTL |
| rs2866074 | chr19:29511152:G:A | - | 0.217869654750819 | 0.000181591138506573 | LUSC | Female-baised eQTL |
| rs115956253 | chr19:29513306:A:G | - | 0.217869654750819 | 0.000181591138506573 | LUSC | Female-baised eQTL |
| rs35981416 | chr19:29515277:T:C | - | 0.217869654750819 | 0.000181591138506573 | LUSC | Female-baised eQTL |
| rs35927641 | chr19:29515959:G:A | - | 0.217869654750819 | 0.000181591138506573 | LUSC | Female-baised eQTL |
| rs66500806 | chr19:29517641:G:A | - | 0.217869654750819 | 0.000181591138506573 | LUSC | Female-baised eQTL |
| rs73016660 | chr19:29515826:C:T | - | 0.199835991313845 | 0.000557365060719254 | LUSC | Female-baised eQTL |
| rs56323055 | chr19:29507277:C:T | - | 0.199714973132188 | 0.000562571669535735 | LUSC | Female-baised eQTL |
| rs34112598 | chr19:29500232:G:A | - | 0.196078308137474 | 0.000937517037400625 | LUSC | Female-baised eQTL |
| rs34179184 | chr19:29509582:C:T | - | 0.171861331122709 | 0.00132228290720537 | LUSC | Female-baised eQTL |
| rs11879059 | chr19:29509738:T:C | - | 0.171861331122709 | 0.00132228290720537 | LUSC | Female-baised eQTL |
| rs73046834 | chr19:35589089:G:A | - | 0.192710745843052 | 0.00145247882947548 | LUSC | Female-baised eQTL |
| rs13346721 | chr19:29143669:C:G | - | 0.100428234867543 | 0.00203893908468607 | LUSC | Female-baised eQTL |
| rs73526458 | chr19:29186859:C:T | - | 0.135035211354549 | 0.00342302357062766 | LUSC | Female-baised eQTL |
| rs73526459 | chr19:29187559:T:A | - | 0.135035211354549 | 0.00342302357062766 | LUSC | Female-baised eQTL |
| rs56073023 | chr19:29523015:G:A | - | 0.135366266898607 | 0.0156776246260707 | LUSC | Female-baised eQTL |
| rs12462356 | chr19:38339357:G:C | - | 0.138615349429067 | 0.0241068736468615 | LUSC | Female-baised eQTL |
| rs12460280 | chr19:38339359:T:G | - | 0.138615349429067 | 0.0241068736468615 | LUSC | Female-baised eQTL |
| rs8104253 | chr19:29523712:T:A | - | 0.111744943996748 | 0.0249226234021871 | LUSC | Female-baised eQTL |
| rs12985863 | chr19:29521072:A:C | - | 0.138466886172172 | 0.0252954212952734 | LUSC | Female-baised eQTL |
| rs12986077 | chr19:29521124:A:G | - | 0.138466886172172 | 0.0252954212952734 | LUSC | Female-baised eQTL |
| rs12971708 | chr19:29521391:A:T | - | 0.138466886172172 | 0.0252954212952734 | LUSC | Female-baised eQTL |
| rs10404747 | chr19:29138150:G:A | - | 0.0944562941889858 | 0.0274033724305759 | LUSC | Female-baised eQTL |
| rs56229322 | chr19:41525085:T:C | - | 0.116185467466478 | 0.0413879253186665 | LUSC | Female-baised eQTL |
| rs57590464 | chr19:41526556:T:A | - | 0.116185467466478 | 0.0413879253186665 | LUSC | Female-baised eQTL |
| rs7259777 | chr19:44109892:G:A | - | 0.107185086335924 | 0.0360969499820322 | KIRC | Female-baised eQTL |
| rs10407453 | chr19:28865409:C:T | - | 0.113921930382309 | 2.85755646019896e-08 | LUAD | Female-baised eQTL |
| rs16962188 | chr19:28863001:C:A | - | 0.113720908033265 | 3.15811588383385e-08 | LUAD | Female-baised eQTL |
| rs16962208 | chr19:28874405:G:A | - | 0.0964004092167896 | 3.91508878623839e-07 | LUAD | Female-baised eQTL |
| rs16962199 | chr19:28873227:C:A | - | 0.0943066100110389 | 6.51895565726858e-07 | LUAD | Female-baised eQTL |
| rs35139012 | chr19:28879331:C:T | - | 0.0852158425818279 | 1.01381013227157e-06 | LUAD | Female-baised eQTL |
| rs76888797 | chr19:27841463:G:T | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs2867091 | chr19:27842601:T:G | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs75396224 | chr19:27845792:G:A | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs79358680 | chr19:27845831:G:A | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs56173563 | chr19:27848711:C:G | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs2286905 | chr19:27849659:A:G | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs112000252 | chr19:27853648:C:T | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs146519905 | chr19:27854507:G:A | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs139928026 | chr19:27857405:T:A | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs73535004 | chr19:27860196:G:A | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs114842370 | chr19:27862124:G:A | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs114151257 | chr19:27862125:G:A | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs147219438 | chr19:27863787:T:A | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs55649813 | chr19:27872434:C:T | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs112913551 | chr19:27873230:C:T | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs16968285 | chr19:27873345:G:C | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs56378599 | chr19:27874229:C:T | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs60329579 | chr19:27880061:A:G | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs73535019 | chr19:27881405:A:G | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs79163884 | chr19:27885455:T:C | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs73535028 | chr19:27887926:C:T | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs16968486 | chr19:27888764:A:T | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs16968489 | chr19:27890098:G:C | - | 0.0934566611704761 | 6.37464935038552e-05 | LUAD | Female-baised eQTL |
| rs73533095 | chr19:27852017:C:G | - | 0.0866251704495711 | 0.000226728659227718 | LUAD | Female-baised eQTL |
| rs875681 | chr19:27860326:T:G | - | 0.0866251704495711 | 0.000226728659227718 | LUAD | Female-baised eQTL |
| rs370714813 | chr19:27273623:G:A | - | 0.0887094695056295 | 0.000686530046935023 | LUAD | Female-baised eQTL |
| rs112460339 | chr19:27576064:C:T | - | 0.0849539216164247 | 0.00105147890353276 | LUAD | Female-baised eQTL |
| rs73535040 | chr19:27894057:G:T | - | 0.0882567268225467 | 0.00118834385525621 | LUAD | Female-baised eQTL |
| rs149237962 | chr19:27856126:G:A | - | 0.0764409870185707 | 0.00158784390053516 | LUAD | Female-baised eQTL |
| rs1978220 | chr19:28455871:T:C | - | -0.0379600497279453 | 0.00538677024560364 | LUAD | Female-baised eQTL |
| rs1978219 | chr19:28455865:A:G | - | -0.0363064473960271 | 0.0384609916401169 | LUAD | Female-baised eQTL |
| rs79147313 | chr19:28122193:T:C | - | 0.052981369344218 | 0.0424923675845025 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7257486 | chr19:32725923:A:G | - | 0.143932049416931 | 5.16238757260641e-05 | THCA | Male-baised eQTL |
| rs10405389 | chr19:33882012:C:A | - | -0.0886793749375617 | 0.0137044610993851 | COAD | Male-baised eQTL |
| rs12976194 | chr19:33882027:C:T | - | -0.0886793749375617 | 0.0137044610993851 | COAD | Male-baised eQTL |
| rs4805942 | chr19:33887228:C:G | - | -0.0824324817370074 | 0.0376360641124468 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Gene ID: ENSG00000161249 | |
| CpG Site: cg17662083 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.469886010849174 |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg17662083 | chr19:35513730 | promoter | -0.469886010849174 | 1.31650238622566e-20 | -0.7390660669162377 | 2.0959116210393114e-24 | HNSC |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_317443 | chr19:35509910:35509961 | In-frame | rs12459642 | chr19:34852789:A:G | Distant downstream | -0.029471335962675 | 0.0405603159867971 | KIRP | Male-baised sQTL |
| exon_skip_317443 | chr19:35509910:35509961 | In-frame | rs17718761 | chr19:34853743:G:C | Distant downstream | -0.0293010344736145 | 0.0454442563227185 | KIRP | Male-baised sQTL |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| EX ID: exon_skip_317443 | |
| CpG Site: cg02878461 | |
| Position to EX: Distant upstream | |
| Male Effect: 0.177473979302048 | |
| Female Effect: - |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_317443 | chr19:35509910:35509961 | cg02878461 | chr19:36033552 | Distant upstream | 0.177473979302048 | 5.48593484096043e-05 | 0.512969623388642 | 1.7121669287310723e-07 | In-frame | PAAD |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of DMKN |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |